INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-2215842261-lab-scientist-looking-down-research]( "Silencing CDMO Project Noise: The Power Of Low-Drama Drug Development")
Silencing CDMO Project Noise: The Power Of Low-Drama Drug DevelopmentMove beyond reactive firefighting by prioritizing disciplined leadership and data-driven milestones. The winning model for complex programs is focused, high-maturity, low-drama execution.
-
![GettyImages-1184711342-imaging-cancer-cells]( "Studying The Spatial Architecture Of Glioblastoma")
Studying The Spatial Architecture Of GlioblastomaExplore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).
-
![Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders Alzheimer's Disease]( "Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders: Alzheimer's Disease")
Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders: Alzheimer's DiseaseExplore how genetic and environmental risk factors interact to heighten Alzheimer's disease risk, and gain insight into a novel therapeutic approach.
-
![drug-develop-pharma-manufactur-GettyImages-686873288]( "High Potency APIs And The Evolving Demands Of Drug Development")
High Potency APIs And The Evolving Demands Of Drug DevelopmentSee how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.
-
Accelerate Your pDNA And mRNA Process Development11/13/2025
Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.
-
Nasal Delivery: Strategies For Success3/2/2026
A strengthened partnership enhances manufacturing for an ultra‑rare disease therapy, leveraging advanced containment upgrades to improve safety, reliability, capacity, and maintain global patient access.
-
Characterizing Binding Interactions By ITC4/24/2025
Isothermal Titration Calorimetry is a powerful technique for analyzing biochemical binding events, which is crucial for understanding molecular interactions and enzyme kinetics in biomedical research.
-
IP Considerations In Drug Development For Biotech Companies4/20/2026
Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.
-
Navigating Challenges During Formulation Development9/11/2024
Gain valuable knowledge on addressing formulation stability, improving product shelf life, and enhancing overall product performance in biopharmaceutical studies.
DRUG DEVELOPMENT SOLUTIONS
-
![Brochure Feature]( "Microcalorimetry: ITC & DSC")
Discover three solutions that provide the performance, reliability, and ease-of-use required for the most demanding applications in drug discovery, protein-protein interactions, structure-function characterization, and more.
-
![molecular-devices-spectramax-quickdrop]( "One-Touch DNA, RNA, And Protein Quantitation In A Spectrophotometer")
Standalone instrument with touchscreen and built-in sample ports for small volumes and cuvettes
The SpectraMax® QuickDrop™ Micro-Volume Spectrophotometer quantifies very small amounts of DNA, RNA, oligos, and proteins.
-
![peptide-cdmo-GettyImages-185209542]( "Peptide CDMO Services")
Learn how peptide‑synthesis platforms, early impurity control, and optimized downstream methods boost scalability, stability, and development speed from early design to late‑stage readiness.
-
![shutterstock_1232765038]( "Maximizing Impact With High-Purity, And Non Animal Origin Squalene")
Enabling you to design vaccines without reliance on animal sources with our fermentation-produced squalene.
-
![GettyImages-2187764040-cell-culture-testing-manufacturing-in-lab]( "Laboratory Services")
Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.
